Recommendation
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9289427/PubMed Central (PMC)Dostarlimab, a boon or a healthcare burden- too early to acertain ...The cost of each dose of the drug is $11,000 (Rs. 8,54,119/-) € 19355 (Rs 16,07,316/-) and Rs. 3.4 lakh/vial in India. Is this amount affordable by all members ...
- https://pubmed.ncbi.nlm.nih.gov/36330672/PubMedDostarlimab for recurrent mismatch repair-deficient endometrial ...Although the agent is substantially more costly, dostarlimab became cost-effective when its cost was reduced to $5489 per cycle. Keywords: cost-effectiveness; ...
- https://en.wikipedia.org/wiki/DostarlimabDostarlimab - WikipediaDostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer.
- https://everyone.org/jemperli-dostarlimabBuy Jemperli (dostarlimab) Online • Price & Costs | Everyone.orgJemperli (dostarlimab) is a programmed death receptor-1 (PD-1)-blocking antibody, for use in: It is available in vial form for intravenous infusion, containing ...
- https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1391896/fullCost-effectiveness of dostarlimab plus chemotherapy for ... - FrontiersJun 20, 2024 ... Dostarlimab in combination with chemotherapy was cost-effective for primary advanced or recurrent dMMR EC from the perspective of a United States payer.
- https://www.ndtv.com/science/10-points-on-dostarlimab-the-drug-that-cured-cancer-during-trials-3049609www.ndtv.com10 Points On Dostarlimab, The Drug That 'Cured' Cancer During TrialsJun 8, 2022 ... According to New York Times, the medicine costs nearly $11,000 or Rs 8.55 lakh per dose. Dostarlimab works by "unmasking" cancer cells, which in ...
- https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/1471-0528.17338Obstetrics and GynecologyDostarlimab for recurrent mismatch repair‐deficient endometrial ...Nov 4, 2022 ... In one-way sensitivity analyses, dostarlimab was cost-effective when its cost was reduced to $4905 (52% reduction). These results were robust in ...
- https://canjhealthtechnol.ca/index.php/cjht/article/view/PC0263/901View of Dostarlimab (Jemperli) | Canadian Journal of Health ...Treatment with Jemperli is expected to cost approximately $13,655 per patient every 28 days. Recommendation. The CADTH pCODR Expert Review Committee (pERC) ...
- https://english.zorginstituutnederland.nl/publications/reports/2024/07/10/package-advice-dostarlimab-jemperliAdvice - reimburse dostarlimab (Jemperli®) for the treatment of ...Jul 10, 2024 ... ... price arrangements for similar medicinal products. It is expected that dostarlimab will also be used for other conditions and that the costs ...
- https://www.ncpe.ie/wp-content/uploads/2022/12/Technical-Summary-Dostarlimab-HTA-ID-21045.docx.pdf1 Cost-effectiveness of dostarlimab (Jemperli®) monotherapy for the ...In June 2022, GlaxoSmithKline (Ireland) Ltd submitted a dossier examining the clinical effectiveness, cost-effectiveness and budget impact of dostarlimab ...
Recommend
All Categories
Others
Privacy Policy
Terms of Use
Welcome to kkinews.com, we strive to provide you with the latest news,
hot topics and in-depth articles.
Whether it's real-time news or in-depth analysis from multiple angles,
you can easily get it here. kkinews.com aims to provide users with a
convenient and comprehensive information acquisition experience to
help you always stay at the forefront of information.
Copyright © 2024 Kkinews. All rights reserved